We are live on ! Find out more
ZURA icon

Zura Bio
ZURA

35 hedge funds and large institutions have $60.7M invested in Zura Bio in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

40% more funds holding

Funds holding: 25 → 35 (+10)

25% more capital invested

Capital invested by funds: $48.5M → $60.7M (+$12.2M)

Holders
35
Holders Change
+10
Holders Change %
+40%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
7
Reduced
1
Closed
2
Calls
$183K
Puts
–
Net Calls
+$183K
Net Calls Change
-$31K

Top Buyers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
+$4.43M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$3.83M
3
Marshall Wace
Marshall Wace
United Kingdom
+$2.02M
4
Millennium Management
Millennium Management
New York
+$1.8M
5
Capstone Investment Advisors
Capstone Investment Advisors
New York
+$985K

Top Sellers

Rank Fund Capital Flow
1
BGIM
Boussard & Gavaudan Investment Management
United Kingdom
-$3.69M
2
OCAM
Owl Creek Asset Management
New York
-$1.48M
3
SSA
Schonfeld Strategic Advisors
New York
-$197K

ZURA Hedge Fund Activity: Q1 2022 in Review

35 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q1 2022, worth a combined $60.7M — up 25% from $48.5M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ZURA positions and 2 closed out — a net gain of 10 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $4.43M. The largest seller was Boussard & Gavaudan Investment Management, exiting entirely with an estimated $3.69M sold.

  • 35 institutional investors held Zura Bio (ZURA) as of Q1 2022, up from 25 in Q4 2021.
  • Funds reported $60.7M of Zura Bio stock for Q1 2022, up 25% quarter-over-quarter.
  • 12 funds opened new Zura Bio positions in Q1 2022 and 2 closed out, a net change of +10 holders.
  • The largest Zura Bio buyer in Q1 2022 was Shaolin Capital Management, an estimated $4.43M added.
  • The largest Zura Bio seller in Q1 2022 was Boussard & Gavaudan Investment Management, an estimated $3.69M sold.

Based on aggregated 13F filings for Q1 2022.